- 【Updated on January 20, 2026】 Integration of CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on November 26, 2025】Regarding the recording of “Research Data” and “Evidence Data”
- CiNii Research researchers search function has been released.
<b>ISOLATION AND CHARACTERIZATION OF CLONES OF A HUMAN LEUKEMIA CELL LINE (HL-60 CELLS) RESISTANT TO 1α,25-DIHYDROXYVITAMIN D<sub>3</sub> AND DIMETHYL </b><b>SULFOXIDE </b>
-
- SENOO HARUKI
- Department of Anatomy, Faculty of Medicine, Tokyo Medical and Dental University
-
- WAKE KENJIRO
- Department of Anatomy, Faculty of Medicine, Tokyo Medical and Dental University
-
- MOMOI TAKASHI
- Division of Pathological Chemistry, National Center for Nervous, Mental and Muscular Disorders
-
- YOSHIKURA HIROSHI
- Department of Bacteriology, Faculty of Medicine, University of Tokyo
Search this article
Description
We have previously demonstrated that HL-60 cells pretreated with 1α,25-dihydroxyvitamin D3 at the stage of commitment were induced to differentiate into macrophage- like cells by dimethyl sulfoxide (OMSO) at the stage of promotion (15). To investigate the effect of OMSO on the differentiation of HL-60 cells induced by 1α,25-dihydroxyvitamin D3, three variant clones (ORHL-1, ORHL-2 and ORHL-3 cells) resistant to 1α,25-dihydroxyvitamin D3 were iso1α,ted from a OMSO-resistant cell clone (ORHL) ofHL-60 cells. These variant clones were insusceptible to 1α,25- dihydroxyvitamin D3 or OMSO, when based on the criteria of cell growth, expression of antigens for human monocyte specific (OKMS) or human granulocyte specific (80H5) monoclona1α,ntibodies, NBT-reducing activity, phagocytosis, nonspecific esterase activity, and cathepsin Band 1α,ctivities. The variant clones, ORHL-1 and ORHL-3, which were insusceptible to 1α,25-dihydroxyvitamin D3 or OMSO alone, were induced to differentiate into macrophage-like cells on simultaneous treatment with 1α,25-dihydroxyvitamin D3 and OMSO. Furthermore, ORHL-1 but not ORHL-3 differentiated into macrophage-like cells on I-day treatment with 1α,,25-dihydroxyvitamin D3 followed by 3-day treatment with OMSO. The other variant, ORHL-2, did not differentiate with any combination of 1α,25-dihydroxyvitamin D3 and OMSO. These results suggest that OMSO promotes the differentiation of HL-60 cells initiated by 1α,,25-dihydroxyvitamin D3 into macrophages at various stages of differentiation.
Journal
-
- Biomedical Research
-
Biomedical Research 7 (5), 311-319, 1986
Biomedical Research Press
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679878296832
-
- NII Article ID
- 130005399470
-
- ISSN
- 1880313X
- 03886107
-
- HANDLE
- 10295/3063
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- IRDB
- Crossref
- CiNii Articles
- OpenAIRE